Memorandum of Understanding Between the Maryland Department of Health and Mental Hygiene and the Food and Drug Administration

摘要

The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Maryland Department of Health and Mental Hygiene and the Food and Drug Administration. The purpose is to set forth conditions for the utilization of Maryland Medicaid data for the study entitled "Compliance with Liver Testing Labeling Guidelines by Health Care Providers."